STASSI, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 13.048
EU - Europa 4.530
AS - Asia 1.226
AF - Africa 60
OC - Oceania 14
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 9
Totale 18.898
Nazione #
US - Stati Uniti d'America 13.034
IT - Italia 1.632
CN - Cina 654
UA - Ucraina 647
FI - Finlandia 622
DE - Germania 425
SG - Singapore 340
IE - Irlanda 317
GB - Regno Unito 296
SE - Svezia 149
RU - Federazione Russa 123
FR - Francia 77
BE - Belgio 68
CI - Costa d'Avorio 59
RO - Romania 58
IN - India 57
KR - Corea 45
TR - Turchia 38
NL - Olanda 33
JP - Giappone 20
CZ - Repubblica Ceca 18
HK - Hong Kong 18
IR - Iran 18
CH - Svizzera 16
CA - Canada 13
GR - Grecia 12
AU - Australia 10
AT - Austria 9
SA - Arabia Saudita 8
BG - Bulgaria 7
EU - Europa 7
QA - Qatar 7
PL - Polonia 6
BR - Brasile 4
ES - Italia 4
MY - Malesia 4
NZ - Nuova Zelanda 4
CL - Cile 3
EC - Ecuador 3
UZ - Uzbekistan 3
A1 - Anonimo 2
IQ - Iraq 2
KZ - Kazakistan 2
PT - Portogallo 2
RS - Serbia 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LV - Lettonia 1
MX - Messico 1
OM - Oman 1
PK - Pakistan 1
SD - Sudan 1
Totale 18.898
Città #
Fairfield 2.130
Ashburn 1.157
Chandler 1.150
Woodbridge 1.106
Houston 865
Cambridge 787
Wilmington 783
Seattle 768
Ann Arbor 764
Palermo 456
Jacksonville 365
Dublin 315
Medford 261
Singapore 243
Des Moines 200
Altamura 175
Nanjing 175
Princeton 173
New York 164
Boardman 155
Lawrence 141
San Diego 133
Dearborn 109
Tulsa 99
Ludwigshafen am Rhein 76
London 68
Beijing 67
Santa Clara 64
Abidjan 59
Rome 59
Brussels 58
Milan 52
Nanchang 48
Berlin 47
Seongnam 43
Shenyang 43
Falls Church 39
Changsha 38
Bremen 37
Hebei 37
Kumar 36
Tianjin 35
Izmir 33
Los Angeles 31
Munich 30
San Paolo di Civitate 29
Phoenix 28
Jinan 27
Helsinki 26
Jiaxing 26
Redwood City 26
Saint Petersburg 26
Venice 21
Ningbo 20
Chicago 18
Guangzhou 15
Verona 15
Hangzhou 13
Olomouc 13
Pune 13
Taizhou 13
Napoli 12
Norwalk 12
Catania 11
Kilburn 11
Kunming 11
San Mateo 11
Tappahannock 11
Zhengzhou 11
Auburn Hills 10
Stockholm 10
Prescot 9
Tehran 9
Turin 9
Frankfurt am Main 8
Lappeenranta 8
Menlo Park 8
Moscow 8
Tokyo 8
Amsterdam 7
Central 7
Doha 7
Indiana 7
Novara 7
Orange 7
Redmond 7
Central District 6
Den Haag 6
Edinburgh 6
Islington 6
Lanzhou 6
Mumbai 6
Naples 6
Ottawa 6
Paris 6
Washington 6
Alcamo 5
Council Bluffs 5
Florence 5
Ghent 5
Totale 14.309
Nome #
Combined platelet-rich plasma and lipofilling treatment provides great improvement in facial skin-induced lesion regeneration for scleroderma patients 299
High Levels of Exogenous C2-Ceramide Promote Morphological and Biochemical Evidences of Necrotic Features in Thyroid Follicular Cells 261
Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance 231
Squamous cell tumors recruit γδ T cells producing either IL17 or IFNγ depending on the tumor stage 230
IL4 primes the dynamics of breast cancer progression via DUSP4 inhibition 225
CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis 218
DNA methylation of shelf, shore and open sea CpG positions distinguish high microsatellite instability from low or stable microsatellite status colon cancer stem cells 203
Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities 194
Characterization of human γδ T lymphocytes infiltrating primary malignant melanomas 192
miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance 189
Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant 188
By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy 182
Consensus molecular subtypes of colorectal cancer are recapitulated in in vitro and in vivo models 180
Activated thyroid hormone promotes differentiation and chemotherapeutic sensitization of colorectal cancer stem cells by regulating Wnt and BMP4 signaling 179
Colon Cancer Stem Cells: Bench-to-Bedside—New Therapeutical Approaches in Clinical Oncology for Disease Breakdown 178
Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells 176
MUC1 Oncoprotein Promotes Refractoriness to Chemotherapy in Thyroid Cancer Cells 174
Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4 173
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells. 167
Tumor and its microenvironment: a synergistic interplay. 167
Distinctive features of tumor-infiltrating gd T lymphocytes in human colorectal cancer 167
Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4 166
Colorectal Cancer Stem Cells: From the Crypt to the Clinic 162
PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells 162
Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy 160
Cancer stem cell definitions and terminology: the devil is in the details 159
Normal vs cancer thyroid stem cells: the road to transformation 159
Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells. 158
Lipid droplets: A New Player in Colorectal Cancer Stem Cells Unveiled by Spectroscopic Imaging 158
Survivin is regulated by interleukin-4 in colon cancer stem cells 155
Colorectal cancer defeating? Challenge accepted! 155
A BMP7 variant inhibits tumor angiogenesis in vitro and in vivo through direct modulation of endothelial cell biology 154
Cancer Stem Cells Sensitivity Assay (STELLA) in Patients with Advanced Lung and Colorectal Cancer: A Feasibility Study. 153
Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells. 151
Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment 150
CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells 149
PED Mediates AKT-Dependent Chemoresistance in Human Breast Cancer Cells 148
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 148
γδ T cells as a potential tool in colon cancer immunotherapy 147
ΔNp63 drives metastasis in breast cancer cells via PI3K/CD44v6 axis 147
Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs 146
Erythropoietin activates cell survival pathways in breast cancer stem-like cells to protect them from chemotherapy 145
Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. 145
Immunotherapy targeting colon cancer stem cells 144
Induction of annexin-1 during TRAIL-induced apoptosis in thyroid carcinoma cells 142
Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer 141
Mechanisms underlying lineage commitment and plasticity of human γδ T cells. 141
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma 141
IL-4-mediated drug resistance in colon cancer stem cells 138
Isolation and culture of colon cancer stem cells. 136
Therapeutic implications of Cancer Initiating Cells. 136
Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme 135
TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells 135
A multidimensional network approach reveals microRNAs as determinants of the mesenchymal colorectal cancer subtype 135
CHK1 inhibitor sensitizes resistant colorectal cancer stem cells to nortopsentin 135
Heart infarct in NOD-SCID mice: therapeutic vasculogenesis by transplantation of human CD34+ cells and low dose CD34+KDR+ cells 133
Carboxyamidotriazole inhibits cell growth of imatinib-resistant chronic myeloid leukaemia cells including T315I Bcr-Abl mutant by a redox-mediated mechanism. 133
Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer 133
Identification and phenotypic characterization of a subpopulation of T84 human colon cancer cells, after selection on activated endothelial cells 132
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins 132
Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes 131
Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules 131
Colon cancer stem cells: promise of targeted therapy. 130
Estrogens and stem cells in thyroid cancer 130
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. 129
Meeting the Challenge of Targeting Cancer Stem Cells 129
Innovative Therapeutic Strategies Targeting Colorectal Cancer Stem Cells 128
Tumorigenic and metastatic activity of human thyroid cancer stem cells 127
IL-21 regulates the differentiation of a human γδ T cell subset equipped with B cell helper activity. 127
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins 124
Cancer-Initiating Cells from Colorectal cancer Patients Escape from T Cell-Mediated Immunosurveillance In Vitro through Membrane-Bound IL-4 124
Transplantation of low dose CD34+KDR+ cells promotes vascular and muscular regeneration in ischemic limbs 123
Involvement of caspase-3 and GD3 ganglioside in ceramide-induced apoptosis in Farber disease 122
Microenvironment in neuroblastoma: Isolation and characterization of tumor-derived mesenchymal stromal cells 122
Nobiletin and Xanthohumol Sensitize Colorectal Cancer Stem Cells to Standard Chemotherapy 121
Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. 120
The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation. 120
Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer 120
Crucial role of interleukin-4 in the survival of colon cancer stem cells 119
Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers 118
V{gamma}9V{delta}2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells. 116
Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancer 116
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. 115
Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of peripheral ischemia. 115
CANCER STEM CELLS CONTRIBUTE TO THE AGGRESSIVE BEHAVIOUR OF HUMAN EPITHELIAL COLON CANCER. 114
Identification and relevance of the CD95-binding domain in the N-terminal region of ezrin 113
Apoptosis induced by a HIPK2 full-length-specific siRNA is due to off-target effects rather than prevalence of HIPK2-Δe8 isoform. 113
In vivo manipulation of Vgamma9Vdelta2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients. 112
Inhibition of DNA Methylation Sensitizes Glioblastoma for Tumor Necrosis Factor–Related Apoptosis-Inducing igand–Mediated Destruction. 111
Distribution, function and predictive value of tumor-infiltrating γδ T lymphocytes 110
Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells 105
Erratum: By promoting cell differentiation, miR-100 sensitizes basal-like breast cancer stem cells to hormonal therapy 105
Role of Type I and II interferons in colorectal cancer and melanoma 104
ROS and Lipid Droplet accumulation induced by high glucose exposure in healthy colon and Colorectal Cancer Stem Cells 104
Role of apoptosis in autoimmunity 104
CD133 as a target for colon cancer. 103
Cancer cell targeting by CAR-T cells: A matter of stemness 100
ROLE OF IL-4 AND IL-10 CYTOKYNES IN THE PATHOGENIC MECHANISM OF THYROID CANCER. 100
Autocrine production of IL-4 confers resistance to chemotherapy and CD-95 induced cell death in cancer cells. 99
Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. 99
Totale 14.525
Categoria #
all - tutte 77.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.374


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.790 0 0 0 566 543 597 490 332 499 292 276 195
2020/20213.083 148 292 187 347 234 108 260 264 288 402 290 263
2021/20222.621 145 503 100 82 151 97 143 140 301 319 187 453
2022/20233.272 310 584 59 404 343 564 184 225 370 39 129 61
2023/20241.506 88 211 93 91 116 301 161 98 17 48 18 264
2024/2025692 110 257 196 129 0 0 0 0 0 0 0 0
Totale 19.829